Blueprint studio · Spec sheets · Amber callouts · Free shipping over $75

brasseriedesindecis.be Blueprint · Rev.39

Sheet A · Product board

ghk cu tesamorelin GHK-Cu – 50MG Milligram:7.5mg bpc-157 tb-500 combination studies Relevanz_+7

Unit price

USD27.98

USD64.98

Pay in 4 interest-free payments of $7.00 Learn more

Field rating

4.6

Verified studio score · Spec revision current

Fit · Size

ghk cu tesamorelin

ghk cu tesamorelin GHK-Cu – 50MG Milligram:7.5mg bpc-157 tb-500 combination studies Relevanz_+7

SKU: 33895861826

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 5 - Nov 10

Description

ghk cu tesamorelin GHK-Cu – 50MG Milligram:7.5mg bpc-157 tb-500 combination studies Relevanz_+7

bpc-157 tb-500 combination studies + Combo – True Research Labs Buy BPC-157/ TB-500 UK - Repair –

And doctors are always nearby and willing to collaborate with us

Relevanz_+7

Milligram:7.5mg

A consultation with our medical team and comprehensive cognitive assessment are required to determine if this therapy is appropriate for you.

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)

FOXO4-DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026)

US$ 28.35

4.1 (22 reviews)

foxo4-dri senolytic 2023 2024 study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Full article: Targeting Cellular Senescence –

foxo4-dri senolytic 2023 2024 study improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells Full article: Targeting Cellular Senescence –

US$ 25.65

4.9 (28 reviews)

ES2 rapidly destroys TP53-FOXO4 foci leading to TP53 mediated

US$ 24.00

4.0 (20 reviews)

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

Development of a novel senolytic by precise disruption of FOXO4-p53 complex

US$ 26.49

4.5 (8 reviews)

FOXO4-DRI — Research Peptide

FOXO4-DRI — Research Peptide

US$ 25.15

4.6 (26 reviews)

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI

US$ 23.42

4.4 (10 reviews)

foxo4 dri peptide senolytic 2024 FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI Peptide

foxo4 dri peptide senolytic 2024 FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI Peptide

US$ 22.93

4.4 (22 reviews)

foxo4-dri cancer peptide senolytic 2023 study Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cell-specific Apoptosis Molecular modelling of the FOXO4-TP53 – foxo4 dri cancer FOXO4-DRI PEPTIDE –

foxo4-dri cancer peptide senolytic 2023 study Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cell-specific Apoptosis Molecular modelling of the FOXO4-TP53 – foxo4 dri cancer FOXO4-DRI PEPTIDE –

US$ 29.53

4.1 (22 reviews)

FOXO4-DRI UK | Senolytic Peptide Research

FOXO4-DRI UK | Senolytic Peptide Research

US$ 26.65

4.4 (18 reviews)

FOXO4-DRI: Senolytic Peptide Design and Handling

FOXO4-DRI: Senolytic Peptide Design and Handling

US$ 23.58

4.1 (8 reviews)

PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

US$ 22.10

4.0 (5 reviews)

foxo4-dri senolytic peptide human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial foxo4-dri peptide senolytic study foxo4 –

foxo4-dri senolytic peptide human trial regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI 10mg vial foxo4-dri peptide senolytic study foxo4 –

US$ 29.32

4.6 (24 reviews)

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

foxo4-dri senolytic 2024 human trial foxo4 dri trials FOXO4-DRI: The Peptide That Targets Zombie foxo4-dri senolytic peptide human trial –

US$ 25.76

4.3 (20 reviews)

Frontiers

Frontiers

US$ 28.36

5.0 (5 reviews)

FOXO4-DRI Peptide

FOXO4-DRI Peptide

US$ 29.06

4.2 (11 reviews)

FOXO4-DRI

FOXO4-DRI

US$ 22.86

5.0 (13 reviews)

foxo4-dri peptide senolytic 2023 2024 study FOXO4-DRI induces keloid senescent fibroblast –

foxo4-dri peptide senolytic 2023 2024 study FOXO4-DRI induces keloid senescent fibroblast –

US$ 29.62

4.4 (11 reviews)

FOXO4-DRI Peptide

FOXO4-DRI Peptide

US$ 27.87

4.8 (6 reviews)

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation

US$ 20.47

4.5 (28 reviews)

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis

US$ 22.64

4.4 (11 reviews)